Tackling "The Delivery Problem" of Gene Editing-Based Medicines with Mammoth Biosciences' Lucas Harrington

Update: 2024-07-18

Description

We love to hear from our listeners. Send us a message.

Lucas Harrington, Co-Founder and Chief Scientific Officer of Mammoth Biosciences, joins Erin Harris to shed light on the biotech's proprietary ultracompact CRISPR systems to develop potential long-term curative therapies for patients with life-threatening and debilitating diseases. They discuss why in vivo delivery continues to be a bottleneck against the clinical advancement of gene-editing-based medicines and what ultracompact CRISPR systems are designed to do.

Subscribe to the podcast!
Apple | Spotify | YouTube

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Globalization's Impact on Patient Access with ARM's COO, Rita Johnson-Greene

2024-11-2121:39

Improving TCR T-Cell Persistence and Efficacy with Adaptimmune's Dennis Williams

2024-11-0720:52

Live from ARM's Meeting on the Mesa with Kiji Therapeutics' Dr. Miguel Forte

2024-10-2425:26

Pioneering Next-Gen TCR Therapies in Solid Tumors with Neogene Therapeutics’ Carsten Linnemann, Ph.D.

2024-10-1014:18

Optogenetics for Vision Restoration with Ray Therapeutics' Paul Bresge

2024-09-2522:00

A New Approach to Genome Engineering with Tessera Therapeutics' Dr. Michael Severino

2024-09-1228:06

Scaling Allo with Allogene Therapeutics' Dr. Zachary Roberts

2024-08-2925:13

CGT Regulatory Update and Outlook with Dark Horse Consulting's Kimberly Benton, Ph.D.

2024-08-1527:58

Identifying Drug Development Opportunities for DMD with CureDuchenne

2024-08-0129:55

Tackling "The Delivery Problem" of Gene Editing-Based Medicines with Mammoth Biosciences' Lucas Harrington

2024-07-1821:01

TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.

2024-07-0435:30

Synthetic Biology and Programmable mRNA with Strand Therapeutics' Jake Becraft

2024-06-2027:52

Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko

2024-06-0614:52

The Current State of the Global Regulatory Landscape with ISCT's Dr. Bambi Grilley

2024-05-2825:21

Dr. Bruce Levine on ISCT and the Future of CAR-T

2024-05-2331:49

CGTs for HIV Suppression with Addimmune's Dr. Marcus Conant

2024-05-0918:51

Inside BlueRock Therapeutics' Parkinson's Disease Trial with Dr. Ahmed Enayetallah

2024-04-2529:39

Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang

2024-04-1123:08

Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan

2024-03-2819:37

Inside Cellular Rejuvenation Therapies for Age-Related Diseases with Life Biosciences' Sharon Rosenzweig-Lipson, Ph.D.

2024-03-1417:17

00:00

Tackling "The Delivery Problem" of Gene Editing-Based Medicines with Mammoth Biosciences' Lucas Harrington

#box-pro-ellipsis-173224265474233{-webkit-line-clamp:2;}Tackling "The Delivery Problem" of Gene Editing-Based Medicines with Mammoth Biosciences' Lucas Harrington

Tackling "The Delivery Problem" of Gene Editing-Based Medicines with Mammoth Biosciences' Lucas Harrington

Erin Harris

Tackling "The Delivery Problem" of Gene Editing-Based Medicines with Mammoth Biosciences' Lucas Harrington